Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215507 · ClinicalTrials.gov registry record · NA

Timing of Physician Rounds for Antepartum Patients

A NA study of Communication and Physician Rounds, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT07215507: Recruiting NA study of Communication and Physician Rounds, sponsored by Duke University.

NCT07215507 is a NA study of Communication and Physician Rounds that is actively recruiting participants, run by Duke University. The registered enrollment target is 200 participants, below the 1,415-participant average among 34 other Communication trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215507, a NA study of Communication and Physician Rounds, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

This study will include patients admitted to the Antepartum service at Duke University Hospital, many of whom are managing high-risk pregnancies that require extended hospital stays and frequent physician interactions. Currently, two rounding methods are used interchangeably for patients who do not have pregnancy or delivery complications that would preclude participation in delayed daytime rounding. This randomized controlled trial will compare two rounding models: the standard model, in which patients receive two rounds (an early morning bedside encounter and a later team discussion), and the intervention model, which consolidates both rounds into a single, later-morning bedside encounter following the team's review of clinical data. The primary objective is to assess whether consolidating physician rounds into a single, later-morning encounter-referred to as discovery rounding-improves patient satisfaction with communication.

Primary Outcome

The CAT measures patients' perceptions of physician communication across 15 specific behaviors, such as listening carefully, showing respect, explaining information clearly, and spending sufficient time with the patient. Each item is rated on a 5-point Likert scale ranging from "Poor" to "Excellent." By focusing on the frequency of "Excellent" ratings, the CAT provides a robust, patient-centered measure of the effectiveness and impact of physician communication during hospitalization.

Interventions

  • BEHAVIORAL Discovery Rounding
  • BEHAVIORAL Standard Rounding

Study Locations (2)

North Carolina

  • Duke University Hospital - Durham
  • Duke University Hospital - Durham

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-11-04
Est. Completion 2027-02-20
Phase NA
Duke University

1,725 total trials

What NCT07215507 shows while recruiting

NCT07215507 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,415-participant average among 34 other Communication trials with a reported enrollment target (86% lower).

The record links to 2 conditions, with Communication appearing as the primary indexed condition, and to 2 interventions - of which Discovery Rounding is the first listed.

NCT07215507 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07215507 about?

NCT07215507 is a clinical study titled "Timing of Physician Rounds for Antepartum Patients". This study will include patients admitted to the Antepartum service at Duke University Hospital, many of whom are managing high-risk pregnancies that require extended hospital stays and frequent physician interactions. Currently, two rounding methods are used interchangeably for patients who do not ...

What is the current status of trial NCT07215507?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-11-04. Estimated completion is 2027-02-20.

What conditions does trial NCT07215507 study?

This clinical trial studies the following conditions: Communication, Physician Rounds.

What interventions are being tested in trial NCT07215507?

The interventions under investigation include: Discovery Rounding (BEHAVIORAL), Standard Rounding (BEHAVIORAL).

Who is sponsoring clinical trial NCT07215507?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07215507 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07215507's enrollment target sits among peer trials

200 26th of 34 higher than 8 of 34 other Communication trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07215507, the US trial registry maintained by the National Library of Medicine. NCT07215507 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.